TRAINING PROGRAM IN MOLECULAR ONCOLOGY AND IMMUNOLOGY
Project Number5T32CA009161-25
Contact PI/Project LeaderDEFENDI, VITTORIO
Awardee OrganizationNEW YORK UNIVERSITY SCHOOL OF MEDICINE
Description
Abstract Text
DESCRIPTION: Program Characteristics: In this application, support is requested for continuation of the training program in molecular oncology and immunology at the New York University (NYU) Medical Center. Emphasis is placed on a combined education in molecular oncology and immunology for a better understanding of the regulatory mechanisms involved in cellular transformation and immunological cell responses. Thus, the general aim is to understand the molecular basis of oncogenic transformation with the identification of the genes responsible for the tumorigenic conversion and their mechanism of action. The immunological component will focus on an understanding at the molecular level of the cell interactions responsible for the activation of the immune response. Dr. Vittorio Defendi, the Director of the program, feels that cross-fertilization of these two disciplines allows the development of new approaches to studies of both oncogenes and of immunologically competent cells and fosters the development of translational research in cancer. There are four components that contribute substantially to this program. First, the Sackler Institute of Graduate Medical Studies was organized to improve biomedical education through inter- disciplinary planning among the basic science departments. At present, 208 students are enrolled in this institute, and Molecular Oncology and Immunology is one of six programs. Second, the NYU Cancer Center, established in 1977, constitutes a major resource of this training program. Dr. Defendi is also Director of the Cancer Center; it has 162 members organized into eight programs. Third, the Division of Pathology is directed by Dr. Nussenzweig. One major focus of this division is T cell recognition and antigen processing. Fourth, the newly established Skirvall Institute of Biomolecular Medicine is newly organized into four programs of molecular pathogenesis, molecular neurosciences, developmental genetics and structural biology; this institute will involve the addition of approximately 40 new scientists during the next three years. The program, although primarily based in the Department of Pathology, functions at the interdepartmental level.
No Sub Projects information available for 5T32CA009161-25
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5T32CA009161-25
Patents
No Patents information available for 5T32CA009161-25
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5T32CA009161-25
Clinical Studies
No Clinical Studies information available for 5T32CA009161-25
News and More
Related News Releases
No news release information available for 5T32CA009161-25
History
No Historical information available for 5T32CA009161-25
Similar Projects
No Similar Projects information available for 5T32CA009161-25